Celldex Therapeutics
CLDX
#4495
Rank
NZ$4.05 B
Marketcap
NZ$51.62
Share price
-0.23%
Change (1 day)
46.33%
Change (1 year)

Market capitalization of Celldex Therapeutics (CLDX)

Market cap: NZ$4.05 Billion

As of May 2026 Celldex Therapeutics has a market cap of NZ$4.05 Billion. This makes Celldex Therapeutics the world's 4495th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celldex Therapeutics from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$4.05 B33.76%
2025NZ$3.02 B1.41%
2024NZ$2.98 B-12.91%
2023NZ$3.42 B3.73%
2022NZ$3.30 B25.07%
2021NZ$2.64 B174.9%
2020NZ$0.96 B1611.17%
2019NZ$56.19 M6.2%
2018NZ$52.91 M-90.27%
2017NZ$0.54 B5.09%
2016NZ$0.51 B-77.11%
2015NZ$2.26 B8.34%
2014NZ$2.08 B-20.63%
2013NZ$2.62 B400.86%
2012NZ$0.52 B256.94%
2011NZ$0.14 B-14.09%
2010NZ$0.17 B-15.97%
2009NZ$0.20 B-5.46%
2008NZ$0.21 B345%
2007NZ$48.42 M-65.93%
2006NZ$0.14 B-30.32%
2005NZ$0.20 B-2.31%
2004NZ$0.20 B-23.44%
2003NZ$0.27 B108.45%
2002NZ$0.13 B-77.59%
2001NZ$0.58 B-34.15%
2000NZ$0.88 B289.9%
1999NZ$0.22 B61.08%
1998NZ$0.14 B26.89%
1997NZ$0.11 B142.98%
1996NZ$45.78 M

End of Day market cap according to different sources

On May 19th, 2026 the market cap of Celldex Therapeutics was reported to be:

NZ$4.05 Billion
by Nasdaq info icon info icon
NZ$4.05 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$250.39 B 6,079.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$305.78 B 7,447.11%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$175.38 B 4,228.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
NZ$10.49 M-99.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
NZ$73.88 B 1,723.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.22 B-94.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.71 B-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA